Search results
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters via AOL· 2 days ago(Reuters) -Novavax on Friday said it had struck a licensing deal worth at least $1.2 billion with...
Why Novavax Stock More Than Doubled Today | The Motley Fool
The Motley Fool· 1 day agoShares of Novavax (NVAX 98.66%) are up 12% as of midday Friday following the release of the...
Why Novavax Stock More Than Doubled Today
Motley Fool via Yahoo Finance· 1 day agoShares of Novavax (NASDAQ: NVAX) are up 12% as of midday Friday following the release of the drugmaker's first-quarter results. It's not the report,...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
AOL· 1 day agoNovavax stock (NVAX) skyrocketed on Friday, nearly doubling on the news French drug and vaccine giant Sanofi (SNY) would invest $1.2 billion in a deal for Novavax ...
Novavax Stock Surges 140% on $1.4 Billion Deal With Sanofi
Barrons.com· 1 day agoNovavax the pharmaceutical company that last year warned that falling sales of its Covid-19 vaccine...
Novavax shares skyrocket after billion-dollar licensing deal with Sanofi
Proactive Investors· 1 day agoNovavax, Inc. (NASDAQ:NVAX) shares surged Friday following the announcement of a significant...
Novavax shares skyrocket after billion-dollar licensing deal with Sanofi By Proactive Investors
Investing.com· 1 day agoNovavax, Inc. (NASDAQ:NVAX) shares surged Friday following the announcement of a significant...
Novavax Stock More Than Doubles After Sanofi Vaccine-Licensing Deal
The Wall Street Journal· 1 day agoNovavax shares (NVAX) surged after the vaccine maker said it had struck a licensing deal worth up to...
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop...
CNBC· 2 days agoA health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization...
Novavax’s top shareholder Shah Capital ramps up efforts for board shakeup
WHTC 1450 Holland· 5 days ago(Reuters) - Hedge fund Shah Capital on Monday urged Novavax shareholders to vote against the...